GlycoNex Incorporation

GlycoNex Incorporationverified

4168.TWO

Price:

$21.6

Market Cap:

$2.33B

GlycoNex Incorporation engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan. The company's development pipeline for the treatment of solid tumors includes GNX102, a humanized monoclonal antibody, currently under phase 1 clinical stage; GNX201, an antibody drug currently under lead optimization stage; GNX202, an antibody drug currently under preclinical stage; and GNX203 and GNX204, antibody drugs currently under target validation stage. It is also involved in the development of SPD (Denosumab), a humanized IgG2 antibody that is in preclinical stage for the treatment of osteoporosis and oncology; and SEA (Aflibercept),...[Read more]

Industry

Biotechnology

IPO Date

2012-06-20

Stock Exchange

TWO

Ticker

4168.TWO

The PE Ratio as of December 2025 (TTM) for GlycoNex Incorporation (4168.TWO) is -10.75

According to GlycoNex Incorporation’s latest financial reports and current stock price. The company's current PE Ratio is -10.75. This represents a change of -17.93% compared to the average of -13.10 of the last 4 quarters.

GlycoNex Incorporation (4168.TWO) Historical PE Ratio (quarterly & annually)

How has 4168.TWO PE Ratio performed in the past?

The mean historical PE Ratio of GlycoNex Incorporation over the last ten years is -13.57. The current -10.75 PE Ratio has changed 7.82% with respect to the historical average. Over the past ten years (40 quarters), 4168.TWO's PE Ratio was at its highest in in the June 2023 quarter at 199.06. The PE Ratio was at its lowest in in the June 2024 quarter at -16.52.

Quarterly (TTM)
Annual

Average

-13.57

Median

-14.72

Minimum

-17.45

Maximum

-6.20

GlycoNex Incorporation (4168.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of GlycoNex Incorporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 152.61%

Maximum Annual PE Ratio = -6.20

Minimum Annual Increase = -32.39%

Minimum Annual PE Ratio = -17.45

Quarterly (TTM)
Annual
YearPE RatioChange
2024-11.80-32.39%
2023-17.4526.70%
2022-13.78-16.62%
2021-16.525.46%
2020-15.67152.61%

GlycoNex Incorporation (4168.TWO) Average PE Ratio

How has 4168.TWO PE Ratio performed in the past?

The current PE Ratio of GlycoNex Incorporation (4168.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-14.34

5-year avg

-15.04

10-year avg

-13.57

GlycoNex Incorporation (4168.TWO) PE Ratio vs. Peers

How is 4168.TWO’s PE Ratio compared to its peers?

GlycoNex Incorporation’s PE Ratio is greater than TaiRx, Inc. (-17.86), greater than Steminent Biotherapeutics Inc. (-14.95), greater than Hcmed (-12.59), less than Intech Biopharm Corporation (-6.72), greater than Gwo Xi Stem Cell Applied Technology Co. , Ltd (-38.51), less than Taiwan Bio Therapeutics Co., Ltd (-5.63), less than Sunny Pharmtech Inc. (-7.79), greater than Anti-Microbial Savior BioteQ Co., Ltd (-28.96), less than HeXun Biosciences Co., Ltd. (15.45), less than Genomics BioSci & Tech. Co.,Ltd. (-10.47),

Build a custom stock screener for GlycoNex Incorporation (4168.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GlycoNex Incorporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GlycoNex Incorporation (4168.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GlycoNex Incorporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is GlycoNex Incorporation's PE Ratio?

How is the PE Ratio calculated for GlycoNex Incorporation (4168.TWO)?

What is the highest PE Ratio for GlycoNex Incorporation (4168.TWO)?

What is the 3-year average PE Ratio for GlycoNex Incorporation (4168.TWO)?

What is the 5-year average PE Ratio for GlycoNex Incorporation (4168.TWO)?

How does the current PE Ratio for GlycoNex Incorporation (4168.TWO) compare to its historical average?